Bruce J. Seeley

Nessuna posizione attualmente

59 anni

Health Technology

Consumer Services

Storia della carriera di Bruce J. Seeley

Precedenti posizioni note di Bruce J. Seeley

Società	Posizione	Inizio	Fine
CTI BIOPHARMA CORP.	Direttore Amministrativo	13/03/2017	26/09/2017
	Direttore operativo	26/09/2017	10/10/2022
	Direttore Finanziario/CFO	13/03/2017	26/09/2017
	Corporate Officer/Principal	01/07/2015	13/03/2017
	Segretario Aziendale	13/03/2017	-
NANOSTRING TECHNOLOGIES, INC.	Corporate Officer/Principal	29/05/2012	01/03/2015
SEAGEN INC.	Corporate Officer/Principal	14/10/2009	24/02/2012
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Vendite & Marketing	01/10/2009	01/10/2009
Aventis Pharmaceuticals, Inc. Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.	Vendite & Marketing	01/01/1996	01/01/2004

Formazione di Bruce J. Seeley

University of California, Los Angeles

Undergraduate Degree

Statistiche

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Sales & Marketing	2
Undergraduate Degree	1

Settori

Health Technology	6
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	1
NANOSTRING TECHNOLOGIES, INC.	Health Technology

Aziende private	4
Seagen Inc. Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
Aventis Pharmaceuticals, Inc. Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.	Health Technology
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.	Health Technology

Vedi le connessioni aziendali